GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

NCT05183243 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
68
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Suzhou Genhouse Bio Co., Ltd.